News/ News/ R&D SwanBio raises $56m for rare neurological disease gene therapy Phil Taylor adrenoleukodystrophy, financing, gene therapy, SwanBio Therapeutics 0 Comment SwanBio Therapeutics has raised $56 million in a second-round financing that will be used to advance its lead Share X SwanBio raises $56m for rare neurological disease gene therapy https://pharmaphorum.com/news/swanbio-raises-56m-for-rare-neurological-disease-gene-therapy/